Back to Search
Start Over
Reply to 'Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+ breast cancer'
- Source :
- CancerREFERENCES. 128(16)
- Publication Year :
- 2022
- Subjects :
- Cancer Research
Oncology
Receptor, ErbB-2
Humans
Breast Neoplasms
Female
Trastuzumab
Subjects
Details
- ISSN :
- 10970142
- Volume :
- 128
- Issue :
- 16
- Database :
- OpenAIRE
- Journal :
- CancerREFERENCES
- Accession number :
- edsair.doi.dedup.....e704bf5551a8f7b582c2c4aa060c32ac